Skip to main content

Market Overview

Transparent Mouse May Bring In 'Wealth Of Potential' To Cancer Research

Share:
Transparent Mouse May Bring In 'Wealth Of Potential' To Cancer Research

A new scanning method that involves a see-through mouse could revolutionize how cancer drugs are tested by detecting tumors that were previously too small to identify, BBC News reports.

Revolutionary Scanning Method

Prof. Ali Ertürk of the Helmholtz Munich research centre has developed a technique to make a dead mouse transparent and highlight specific tissues for detailed scanning. This method reveals more detail than existing scanning techniques, allowing the detection of cancerous tumors in their earliest stages.

Cancer Research UK has helmed the new scanning technique to have “a wealth of potential”.

Implications for Cancer Research

Prof Ertürk emphasized the importance of this development, stating, “MRI and PET scans would show you only big tumors. Ours show tumors at the single cell, which they absolutely can’t.”

He further explained that current drugs extend life by a few years before the cancer returns, often because the tiny tumors were never visible and thus not completely eliminated during the development process.

See Also: Panbela’s Diverse Pipeline Is Encouraging Amidst Challenges In Pancreatic Cancer: The Analyst’s Take

Future Applications

While the scanning method can only be used on dead mice currently, it could potentially be applied to any animals and even human tissues and organs. This could provide unprecedented insights into disease development and the impact of different drugs and treatments, accelerating the pace of medical research.

Read Next: Infinity Pharmaceuticals Says Second Proxy Advisory Firm Recommends Shareholders To Approve Proposed Merger

Photo by louis-reed for Unsplash

Benzinga Newsbot

Hi, I am the Benzinga Newsbot!
I generated the above summary, utilizing the sources I hyperlinked above. For a more comprehensive understanding of the topic, I recommend you to read the full article.

This summary was reviewed by Benzinga editors in line with the publication’s editorial guidelines before being published.

 

Related Articles

View Comments and Join the Discussion!

Posted-In: cancer research mice TransparentBiotech News Health Care Media General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com